Member Info for Ronnycant

I got spiked at 1.65 a few hours back. Thank God it is getting back to that level :-)

Unfortunately not me. Just bought 5000 shares after having had it on the watchlist for 6 months. This price level is too good to pass up. FDA approval, great versatile technology... one off worldwide, and now cashed up. Sit back and relax... This one can do well.. very well

Maybe discuss that on the "economy" board.

8GBP/Share... AVCT has broken my investment-spirit... I'll take it :-o

12.000 BOE/day was mentioned in the latest RNS "Value Creation Plan"...

Notes to editors

Kistos plc was established to acquire and manage companies in the energy sector engaging in the energy transition trend. The Company has acquired Tulip Oil Netherlands B.V., which has a portfolio of assets, including profitable, highly cash generative natural gas production, plus appraisal and exploration opportunities. The Company has 19.5 MMboe of 2P reserves and an additional 102.1 MMboe of contingent resources. On 31st January 2022, Kistos announced that it had conditionally agreed to acquire a 20% interest in the Greater Laggan Area from TotalEnergies. On completion, this transaction is expected to increase Group production to ~12,000 boe/d and add 2P reserves of 6 MMboe

You are right...

Producing about 12000 BOE/day... TTF is in BOE...

Profit or revenue?

Holding AVCT has been a near nightmare. Maybe against better judgement, I am holding since I believe in AVA. But what a disappointment so far. Even 1GBP/share seems like a fata morgana.

You mean "profit"...

These days is hunker down mode. Lost 15% of my PF yesterday on SNG. Heavily in AVCT and KIST (50%), all whilst being slightly leveraged. Today is an exercise in keeping the head cool, which is not straightforward. AVACTA today is priced to fail. I believe the Precision will not, hence I stay in. KIST is the cash-cow share that needs to balance out and buffer for any AVACTA failure.

I decided to diversify a while ago (hence adding some SNG, KIST), but in truth, some luck is always required, even if you balance risk. The issue is that in the last 5 months, luck has been lacking severely which is frustrating. Way forward: Keep the head cool, don't sell at the bottom (like I did back with RRE when corona popped up) and ride this out. Good luck!

Just saying

What are you missing? A top-up opportunity right there... in front of you

Basically, they will know if the tumor shows reduction

The dose increase indeed shows that there is reduced toxicity in healthy tissue. The big question remains, how much increase of chemo can be observed in the actual tumor area. That will define how effective the treatment will be. PS. I increased my already oversized holding

I am invested... Valid questions testing the investment thesis. Some constructive responses and childish ones.. Many thanks for the constructive ones... Others on ignore. Grow up

That's little money for a +400Mio Marketcap company. Any of these can also be put on leave without too much hassle. It is not bad news, but people are reading too much in this. One could assume they have received feedback... but well... assumptions...

Pretty childish. If my assumption is wrong, then explain where. I'll (again) happily accept corrections.

From what I can read in the RNS, SNG never received the data from the Aktiv2 trial. If so, maybe we are reading too much in them opening job positions in the US (easy hire, easy fire), website update etc... They might just hope for a good phase3 outcome. Their moves might not be on actual preliminary insights of trial data. HAppy to stand corrected.

Any guesses?